MyFinsight
Home
About
Contact
spro: the income statement
Download
Download image
Net loss and
comprehensive loss
-$7,382K
(56.95%↑ Y/Y)
Other income
(expense), net
$2K
(107.69%↑ Y/Y)
Interest income
$532K
(-54.99%↓ Y/Y)
Net loss before
income taxes
-$7,382K
(57.66%↑ Y/Y)
Total other income,
net
$534K
(-53.81%↓ Y/Y)
Collaboration revenue -
related party
$3,048K
(-60.69%↓ Y/Y)
Grant revenue
$2,394K
(-57.63%↓ Y/Y)
Loss from operations
-$7,916K
(57.42%↑ Y/Y)
Total revenues
$5,442K
(-59.60%↓ Y/Y)
Total operating
expenses
$13,358K
(-58.34%↓ Y/Y)
Impairment charges
$587K
General and
administrative
$4,174K
(-19.70%↓ Y/Y)
Research and development
$8,597K
(-68.00%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Spero Therapeutics, Inc. (SPRO)
Spero Therapeutics, Inc. (SPRO)